Skip to main content
Premium Trial:

Request an Annual Quote

WaferGen Strikes Pact with Luxembourg's IBBL; Readies European HQ

Premium

WaferGen BioSystems said today that it inked an agreement with the Integrated BioBank of Luxembourg to co-develop molecular signatures for diagnostic research and commercial applications.

Under the agreement, IBBL will purchase a WaferGen SmartChip Real-Time PCR system and use it to discover and validate gene expression patterns, the company said. In addition, the partners plan to co-develop molecular signatures in cancer and other areas and file for regulatory approval in Europe.

Further, IBBL will offer profiling services in Europe using the SmartChip system, WaferGen said.

WaferGen Chairman and CEO Alnoor Shivji said the alliance "enables WaferGen to access best-annotated patient samples for future diagnostic products. It also establishes a beachhead in Europe to unlock the short- and long-term revenue potential of the WaferGen SmartChip system."

WaferGen also said that it will establish its European headquarters at the IBBL facilities in the "very near future." The company disclosed in March that it reached an agreement with the Luxembourg government to locate its European headquarters in the country (PCR Insider, 3/31/10).

The new Luxembourg location will house Wafergen's European marketing and sales, service and support, distribution, management of any subsidiaries and distributors, IP management, and some R&D activities, the company said.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.